Loading company…
Stämm Biotech provides biomanufacturing systems and cell line development for biologics and cell therapies, using AI-driven tools.
Founded in 2014 in Buenos Aires, Argentina, Stämm Biotech works on biomanufacturing for biologics and cell therapies. Its offerings include automated and continuous manufacturing systems, cell line development support, and AI generative models that build cell-predictive pipelines from multi-omics data. Federico Vegh and Yuyo Vegh are the founders. In January 2022 the company raised USD 17.000 mn in Series A funding led by Varana Capital, which is its total raised to date.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in